Cargando…
Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples
We previously demonstrated that amplified in breast cancer 1 (AIB1) and eukaryotic initiation factor 2 (EIF5A2) overexpression was an independent predictor of poor clinical outcomes for patients with bladder cancer (BCa). In this study, we evaluated the usefulness of AIB1 and EIF5A2 alone and in com...
Autores principales: | Zhou, Bang-Fen, Wei, Jin-Huan, Chen, Zhen-Hua, Dong, Pei, Lai, Ying-Rong, Fang, Yong, Jiang, Hui-Ming, Lu, Jun, Zhou, Fang-Jian, Xie, Dan, Luo, Jun-Hang, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173089/ https://www.ncbi.nlm.nih.gov/pubmed/27203388 http://dx.doi.org/10.18632/oncotarget.9406 |
Ejemplares similares
-
Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma
por: Huang, Yong, et al.
Publicado: (2018) -
AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1
por: Tong, Z-T, et al.
Publicado: (2013) -
The AIBE and the new phase of the RBHH
por: Maiolino, Ângelo
Publicado: (2011) -
Mechanism of 3‐Methylglutaconyl CoA Decarboxylase AibA/AibB: Pericyclic Reaction versus Direct Decarboxylation
por: Sheng, Xiang, et al.
Publicado: (2020) -
Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
por: Charpentier, Marine, et al.
Publicado: (2021)